1. PATH. The case for investment in enterotoxigenic Escherichia coli vaccines. Accessed January 11, 2023. https://www.path.org/resources/the-case-for-investment-in-enterotoxigenic-escherichia-coli-vaccines/
2. Diarrhoeal disease. Accessed February 23, 2020. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
3. Evans DJ, Evans DG. Escherichia coli in diarrheal disease. In: Baron S, ed. Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; 1996. Accessed December 6, 2019. http://www.ncbi.nlm.nih.gov/books/NBK7710/
4. Secretory diarrhoea: mechanisms and emerging therapies;Thiagarajah;Nat Rev Gastroenterol Hepatol,2015
5. Zhang Y, Tan P, Zhao Y, Ma X. Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota. Gut Microbes. 14(1):2055943. doi:10.1080/19490976.2022.2055943